cytori therapeutics inc
(CYTX:Consolidated Issue listed on NASDAQ Global Market)
Kenneth R. Chien M.D., Ph.D.
Scientific Advisor, Cytori Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 29 board members in 2 different organizations across 5 different industries.|
See Board Relationships
Prof. Kenneth R. Chien, M.D., Ph.D, has been a Scientific Advisor of Cytori Therapeutics, Inc. (Formerly Macropore Biosurgery Inc). since June 8, 2005. He is Member of Scientific Advisory Board of Moderna Therapeutics, Inc. Dr. Chien serves as the Charles R. Sanders Endowed Chair in Medicine, of Harvard Medical School. He served as the Director of the Cardiovascular Research Center of Massachusetts General Hospital. He serves as the Chair of Cardiovascular Research of ...
3020 Callan RoadPhone: 858-458-0900
San Diego, California 92121
Board Members Memberships*
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Gil Van Bokkelen Ph.D.||Co-Founder, Chairman and Chief Executive Officer|
|Martin M. McGlynn||Chief Executive Officer, Director, Chief Executive Officer of Stemcells California Inc, President of Stemcells California Inc and Member of Strategic Transactions Committee|
|David J. Mazzo B.A (Hons), B.Sc. (Hons.), M.Sc., Ph.D.||Chief Executive Officer and Director|
|Martin P. Rosendale||Chief Executive Officer and Director|
Nuo Therapeutics, Inc.
|Bernard A. Hausen M.D., Ph.D.||Co-Founder, Chief Executive Officer, President, Chief Medical Officer, Director and Member of Strategic Review Committee|
|$455.8K||Compensation as of Fiscal Year 2014.|